Joshua Rezkalla, MD
Interventional Cardiology · Rochester, MNNPI 1740711829
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 61.0% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $4,404, more than ten times the $19 reported in 2022. That places this record below the midpoint for interventional cardiology clinicians in MN, where the typical reported total is $5,396.
Across 21 payments — averaging $256.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Edwards Lifesciences$859
- Boston Scientific$562
- Abiomed$369
- Teleflex LLC$150
- Penumbra, Inc.$141
- plus $21 from 1 others
What the payments were for
- Speaking & faculty fees$3,06757%
- Travel & lodging$65012%
- Food & beverage$1,45827%
- Education$2214%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $3,293 |
| Edwards Lifesciences | 8 | $859 |
| Boston Scientific | 4 | $562 |
| Abiomed | 3 | $369 |
| Teleflex LLC | 1 | $150 |
| Penumbra, Inc. | 1 | $141 |
| Heartflow, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,396 in reported general payments places this provider in the 50th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 15 | $20,827 |
| Metoprolol Succinate | 24 | $554 |
| Rosuvastatin Calcium | 33 | $446 |
| Atorvastatin Calcium | 22 | $370 |
| Ezetimibe | 12 | $172 |
| ClopidogrelClopidogrel Bisulfate | 24 | $94 |
| Furosemide | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Rochester
- Kelley ChenRochester$14K
- Colleen LaneRochester$14K
- Smitha Narayana GowdaRochester$9K
- Trevor SimardRochester$9K
- Michael SabbahRochester$8K
- Aravdeep JhandRochester$7K
- Mohammed OsmanRochester$4K
- Mohammad SarrafRochester$3K
- Jason SimsRochester$2K
- Conor LaneRochester$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.